The significance of SUMOylation of angiogenic factors in cancer progression

Cancer Biol Ther. 2019;20(2):130-137. doi: 10.1080/15384047.2018.1523854. Epub 2018 Sep 27.

Abstract

Angiogenesis is the process of endothelial cell migration and proliferation induced by angiogenic factors, which is essential for the development of tumors. In recent years, studies have reported that SUMOylation acts on tumor angiogenesis by targeting angiogenic factors as one of post-translational modifications of proteins. Anti-angiogenic therapy is a new treatment method for tumor treatment following radiotherapy and chemotherapy, and it inhibits tumor growth by blocking tumor blood vessels. Therefore, SUMOylation may become a potential target for anti-angiogenesis therapy. This article focuses on the effect of SUMOylation on vascular growth factors, important signaling pathways proteins, and the migration and function of endothelial cells, in order to provide a new research idea for the anti-angiogenic therapy of tumors.

Keywords: SUMOylation; angiogenic factors; cancer.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiogenesis Inducing Agents / metabolism*
  • Disease Progression
  • Humans
  • Neoplasms / genetics*
  • Neoplasms / mortality
  • Sumoylation
  • Survival Rate

Substances

  • Angiogenesis Inducing Agents

Grants and funding

This study was supported by the National Natural Science Foundation of China (NO. 81472792), the Natural Science Foundation of Jiangsu Province, China (No.BK20151279), and the Youth Talents Found of Lianyungang First People’s Hospital (QN160306).